Replies to post #117 on Esperion Therapeutics Inc (ESPR)

[BuckeyeMike]

I think both statements are true. Here's a difficulty I think many Investor's are having with today's language on the FDA's position on CVOT:

$ESPR's previous PR and this one, unfortunately. Which is:

"…will not require (CVOT)"

vs

"…(CVOT) could be required."

That's a pretty big discrepancy from what they originally communicated to investors versus what they said today with HUGE a implication.

Management screwed up.